Evidence map›Paper›PMID 24984194›Full record

ArticleTranslational psychiatry2014

A thermostable bacterial cocaine esterase rapidly eliminates cocaine from brain in nonhuman primates.

L L Howell, J A Nye, J S Stehouwer, R J Voll, J Mun, D Narasimhan, J Nichols, R Sunahara, M M Goodman, F I Carroll and 1 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

L L HowellDivision of Neuropharmacology and Neurologic Diseases, Emory University, Yerkes National Primate Research Center, Atlanta, GA, USA.
J A NyeDivision of Neuropharmacology and Neurologic Diseases, Emory University, Yerkes National Primate Research Center, Atlanta, GA, USA.
J S StehouwerDivision of Neuropharmacology and Neurologic Diseases, Emory University, Yerkes National Primate Research Center, Atlanta, GA, USA.
R J VollDivision of Neuropharmacology and Neurologic Diseases, Emory University, Yerkes National Primate Research Center, Atlanta, GA, USA.
J MunDivision of Neuropharmacology and Neurologic Diseases, Emory University, Yerkes National Primate Research Center, Atlanta, GA, USA.
D NarasimhanDivision of Neuropharmacology and Neurologic Diseases, Emory University, Yerkes National Primate Research Center, Atlanta, GA, USA.
J NicholsDivision of Neuropharmacology and Neurologic Diseases, Emory University, Yerkes National Primate Research Center, Atlanta, GA, USA.
R SunaharaDivision of Neuropharmacology and Neurologic Diseases, Emory University, Yerkes National Primate Research Center, Atlanta, GA, USA.
M M GoodmanDivision of Neuropharmacology and Neurologic Diseases, Emory University, Yerkes National Primate Research Center, Atlanta, GA, USA.
F I CarrollDivision of Neuropharmacology and Neurologic Diseases, Emory University, Yerkes National Primate Research Center, Atlanta, GA, USA.
J H WoodsDivision of Neuropharmacology and Neurologic Diseases, Emory University, Yerkes National Primate Research Center, Atlanta, GA, USA.
Neurological Surgery · USEmory University · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
PET Imaging and Cocaine Neuropharmacology in MonkeysR37DA010344 · NIDA · EMORY UNIVERSITY · PI HOWELL, LEONARD L · 2007 to 2015
$4.9M
PET IMAGING AND COCAINE NEUROPHARMACOLOGY IN MONKEYSR01DA010344 · NIDA · EMORY UNIVERSITY · PI HOWELL, LEONARD L · 1997 to 2006
$2.7M
Neuropharmacology of Abused Stimulants in Nonhuman PrimatesK05DA031246 · NIDA · EMORY UNIVERSITY · PI HOWELL, LEONARD L · 2012 to 2016
$619k
NIDA NIH HHS DA010344NIDA NIH HHS DA031246NIDA NIH HHS K05 DA031246NIDA NIH HHS R01 DA010344NIDA NIH HHS R37 DA010344NIH HHS P51 OD011132PHS HHS ODP51OD11132
6 · The paper itself

Abstract

A long-acting, thermostable bacterial cocaine esterase (CocE) has been identified that rapidly degrades cocaine with a K(M) of 1.33+0.085 μM. In vivo evaluation of CocE has shown protection against convulsant and lethal effects of cocaine in rodents, confirming the therapeutic potential of CocE against cocaine overdose. However, the current study is the first to evaluate the effects of CocE on cocaine brain levels. Positron emission tomogrpahy neuroimaging of [(11)C]cocaine was used to evaluate the time course of cocaine elimination from brain in the presence and absence of CocE in nonhuman primates. Systemic administration of CocE eliminated cocaine from the rhesus-monkey brain approximately three times faster than control conditions via peripheral actions through attenuating the input function from blood plasma. The efficiency of this process is sufficient to alleviate or prevent adverse central nervous system effects induced by cocaine. Although the present study used tracer doses of cocaine to access brain clearance, these findings further support the development of CocE for the treatment of acute cocaine toxicity.

Indexed as

AnimalsBrainCarboxylic Ester HydrolasesCocaineDrug OverdoseEnzyme StabilityMacaca mulattaPositron-Emission TomographyRecombinant ProteinsRhodococcusCarboxylic Ester HydrolasesCocaineCocE proteinRecombinant Proteins

Identifiers

PMID24984194
PMCPMC4119218
OpenAlexW1977817246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.